FARALLON CAPITAL MANAGEMENT LLC Q3 2020 Filing

Filed November 16, 2020

Portfolio Value

$14.1B

Holdings

118

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (118 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	INBXUSDINHIBRX INC	395,000	$7.1M	0.05%
102	BDQMALBIREO PHARMA INC	200,000	$6.7M	0.05%
103	NVLSEURALPINE IMMUNE SCIENCES INC	741,290	$6.5M	0.05%
104	IVAINVENTIVA SA	527,870	$6.2M	0.04%
105	—RADIUS HEALTH INC	6,783,000	$5.5M	0.04%
106	YB4PSAVARA INC	4,452,086	$4.9M	0.03%
107	—ARYA SCIENCES ACQUISTION CO	402,523	$4.4M	0.03%
108	OPHTEURIVERIC BIO INC	754,740	$4.3M	0.03%
109	EQEQUILLIUM INC	700,000	$4.0M	0.03%
110	DYNDYNE THERAPEUTICS INC	200,000	$4.0M	0.03%
111	APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC	3,522,000	$3.8M	0.03%
112	—QUOTIENT LTD	625,000	$3.2M	0.02%
113	CRDFCARDIFF ONCOLOGY INC	200,000	$2.8M	0.02%
114	—FUSION PHARMACEUTICALS INC	187,600	$2.3M	0.02%
115	—BROADMARK RLTY CAP INC	7,174,613	$2.1M	0.01%
116	AMWLAMERICAN WELL CORP	45,000	$1.3M	0.01%
117	—PANDION THERAPEUTICS INC	100,000	$1.1M	0.01%
118	GOLGBPGOL LINHAS AEREAS INTELIGENT	85,838	$524K	0.00%

PreviousPage 2 of 2